Folate-targeted immunotherapy effectively treats established adjuvant and collagen-induced arthritis

Arthritis Research and Therapy

Volumn 8, Issue 3, 2006, Pages

  Paulos, Chrystal M ^a   Varghese, Bindu ^a   Widmer, William R ^b   Breur, Gert J ^b   Vlashi, Erina ^a   Low, Philip S ^a  

^a PURDUE UNIVERSITY   (United States)

^b PURDUE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FOLIC ACID;

ANIMAL; ARTHRITIS, EXPERIMENTAL; DBA MOUSE; DISEASE MODEL; FEMALE; FOLIC ACID DEFICIENCY; IMMUNOLOGY; IMMUNOTHERAPY; LEWIS RAT; MACROPHAGE; MALE; MOUSE; PATHOLOGY; RAT; WEIGHT BEARING;

ANIMALS; ARTHRITIS, EXPERIMENTAL; DISEASE MODELS, ANIMAL; FEMALE; FOLIC ACID; FOLIC ACID DEFICIENCY; IMMUNOTHERAPY; MACROPHAGES; MALE; MICE; MICE, INBRED DBA; RATS; RATS, INBRED LEW; WEIGHT-BEARING;

EID: 34547109974     PISSN: 14786354     EISSN: 14786362     Source Type: Journal    
DOI: 10.1186/ar1944     Document Type: Article

References (35)

1. Kinne RW, Brauer R, Stuhlmuller B, Palombo-Kinne E, Burmester GR: Macrophages in rheumatoid arthritis. Arthritis Res 2000, 2 189-202.
2. Tak PP, Smeets TJ, Daha MR, Kluin PM, Meijers KA, Brand R, Meinders AE, Breedveld FC: Analysis of the synovial cell infiltrate in early rheumatoid synovial tissue in relation to local disease activity. Arthritis Rheum 1997, 40:217-225.
3. Yanni G, Whelan A, Feighery C, Bresnihan B: Synovial tissue macrophages and joint erosion in rheumatoid arthritis. Ann Rheum Dis 1994, 53:39-44.
4. Mulherin D, Fitzgerald O, Bresnihan B: Synovial tissue macrophage populations and articular damage in rheumatoid arthritis. Arthritis Rheum 1996, 39:115-124.
5. Liu H, PoMe RM: Phagocytes: mechanisms of inflammation and tissue destruction. Rheum Dis Clin North Am 2004, 30:19-39.
6. Smolen JS, Steiner G: Therapeutic strategies for rheumatoid arthritis Nat Rev Drug Disco 2003, 2:473-488.
7. Richard-Miceli C, Dougados M: Tumour necrosis factor-alpha blockers in rheumatoid arthritis: Review of the clinical experience. BioDrugs 2001, 15:251-259.
8. Feige U, Hu YL, Gasser J, Campagnuolo G, Munyakazi L, Bolon B: Anti-interleukin-1 and anti-tumor necrosis factor-alpha synergistically inhibit adjuvant arthritis in Lewis rats. Cell Mol Life Sci 2000, 57:1457-1470.
9. Bendele AM, Chlipala ES, Scherrer J, Frazier J, Sennello G, Rich WJ, Edwards CK 3rd: Combination benefit of treatment with the cytokine inhibitors interleukin-1 receptor antagonist and PEGylated soluble tumor necrosis factor receptor type I in animal models of rheumatoid arthritis Arthritis Rheum 2000, 43:2648-2659.
10. Schiff MH: Role of interleukin 1 and interleukin 1 receptor antagonist in the mediation of rheumatoid arthritis. Ann Rheum Dis 2000, 59:i103-i108.
11. Goldenberg MM: Celecoxib, a selective cyclooxygenase-2 inhibitor for the treatment of rheumatoid arthritis and osteoarthritis. Clin Ther 1999, 21:1497-1513.
12. Kato S, Ogawa Y, Kanatsu K, Okayama M, Watanabe T, Arakawa T, Takeuchi K: Ulcerogenic influence of selective cyclooxygenase-2 inhibitors in the rat stomach with adjuvant-induced arthritis. J Pharmacol Exp Ther 2002, 303:503-509.
13. Frantz S: How to avoid another 'Vioxx'. Nat Rev Drug Discov 2005, 4:5-7.
14. Yamada T, Takahashi S, Masuda K, Ohara H, Nakazawa T, Sano H, Ando T, Nakamura S, Kobayashi S, Kuno A, et al.: Kupffer-cell depletion attenuates colonic and extracolonic granulomatous inflammation in chronic colitis. J Lab Clin Med 2003, 142:268-277.
15. Puliti M, von Hunolstein C, Bistoni F, Castronari R, Orefici G, Tissi L: Role of macrophages in experimental group B streptococcal arthritis Cell Microbiol 2002, 4:691-700.
16. Richards PJ, Williams AS, Goodfellow RM, Williams BD: Liposomal clodronate eliminates synovial macrophages, reduces inflammation and ameliorates joint destruction in antigeninduced arthritis. Rheumatology (Oxford) 1999, 38:818-825.
17. Hahn G, Stuhlmuller B, Hain N, Kalden JR, Pfizenmaier K, Burmester GR: Modulation of monocyte activation in patients with rheumatoid arthritis by leukapheresis therapy. J Clin Invest 1993, 91 862-870.
18. Wijngaarden S, van de Winkel JG, Jacobs KM, Bijlsma JW, Lafeber FP, van Roon JA: A shift in the balance of inhibitory and activating Fcgamma receptors on monocytes toward the inhibitory Fcgamma receptor IIb is associated with prevention of monocyte activation in rheumatoid arthritis. Arthritis Rheum 2004, 50:3878-3887.
19. Kawahito Y, Kondo M, Tsubouchi Y, Hashiramoto A, Bishop-Bailey D, Inoue K, Kohno M, Yamada R, Hla T, Sano H: 15-deoxydelta (12,14)-PGJ(2) induces synoviocyte apoptosis and suppresses adjuvant-induced arthritis in rats. J Clin Invest 2000, 106:189-197.
20. Park JE, Barbul A: Understanding the role of immune regulation in wound healing. Am J Surg 2004, 187:11S-16S.
21. Dipietro LA, Reintjes MG, Low QE, Levi B, Gamelli RL: Modulation of macrophage recruitment into wounds by monocyte chemoattractant protein-1 Wound Repair Regen 2001, 9:28-33.
22. Nakashima-Matsushita N, Homma T, Yu S, Matsuda T, Sunahara N, Nakamura T, Tsukano M, Ratnam M, Matsuyama T: Selective expression of folate receptor beta and its possible role in methotrexate transport in synovial macrophages from patients with rheumatoid arthritis. Arthritis Rheum 1999, 42:1609-1616.
23. Turk MJ, Breur GJ, Widmer WR, Paulos CM, Xu LC, Grote LA, Low PS: Folate-targeted imaging of activated macrophages in rats with adjuvant-induced arthritis. Arthritis Rheum 2002, 46 1947-1955.
24. Chen WT, Mahmood U, Weissleder R, Tung CH: Arthritis imaging using a near-infrared fluorescence folate-targeted probe. Arthritis Res Ther 2005, 7:R310-R317.
25. Paulos CM, Turk MJ, Breur GJ, Low PS: Folate receptor-mediated targeting of therapeutic and imaging agents to activated macrophages in rheumatoid arthritis. Adv Drug Deliv Rev 2004, 56 1205-1217.
26. Lu Y, Low PS: Folate targeting of haptens to cancer cell surfaces mediates immunotherapy of syngeneic murine tumors. Cancer Immunol Immunother 2002, 51:153-162.
27. Fletcher DS, Widmer WR, Luell S, Christen A, Orevillo C, Shah S, Visco D: Therapeutic administration of a selective inhibitor of nitric oxide synthase does not ameliorate the chronic inflammation and tissue damage associated with adjuvant-induced arthritis in rats. J Pharmacol Exp Ther 1998, 284:714-721.
28. Wang S, Lee RJ, Mathias CJ, Green MA, Low PS: Synthesis, purification, and tumor cell uptake of 67Ga-deferoxamine - folate, a potential radiopharmaceutical for tumor imaging. Bioconjug Chem 1996, 7:56-62.
29. Welles WL, Silkworth J, Oronsky AL, Kerwar SS, Galivan J: Studies on the effect of low dose methotrexate on rat adjuvant arthritis. J Rheumatol 1985, 12:904-906.
30. Wu Z, Nagata K, Iijima T: Immunohistochemical study of NGF and its receptors in the synovial membrane of the ankle joint of adjuvant-induced arthritic rats. Histochem Cell Biol 2000, 114:453-459.
31. Sandoval RM, Kennedy MD, Low PS, Molitoris BA: Uptake and trafficking of fluorescent conjugates of folic acid in intact kidney determined using intravital two-photon microscopy. Am J Physiol Cell Physiol 2004, 287:C517-C526.
32. Fraser A, Fearon U, Billinghurst RC, Ionescu M, Reece R, Farwich T, Emery P, Poole AR: Turnover of type II collagen and aggrecan in cartilage matrix at the onset of inflammatory arthritis in humans: relationship to mediators of systemic and local inflammation. Arthritis Rheum 2003, 48:3085-3095.
33. Horwitz DA: The development of macrophages from large mononuclear cells in the blood of patients with inflammatory disease. J Clin Invest 1972, 51:760-768.
34. Katschke KJ Jr, Rottman JB, Ruth JH, Qin S, Wu L, LaRosa G, Ponath P, Park CC, Pope RM, Koch AE: Differential expression of chemokine receptors on peripheral blood, synovial fluid, and synovial tissue monocytes/macrophages in rheumatoid arthritis. Arthritis Rheum 2001, 44:1022-1032.
35. Hurlimann D, Enseleit F, Ruschitzka F: Rheumatoid arthritis, inflammation, and atherosclerosis. Herz 2004, 29:760-768.